Machine Learning and Glioblastoma: Treatment Response Monitoring Biomarkers in 2021

no code implementations • 15 Apr 2021 • Thomas Booth, Bernice Akpinar, Andrei Roman, Haris Shuaib, Aysha Luis, Alysha Chelliah, Ayisha Al Busaidi, Ayesha Mirchandani, Burcu Alparslan, Nina Mansoor, Keyoumars Ashkan, Sebastien Ourselin, Marc Modat

The small numbers of patient included in studies, the high risk of bias and concerns of applicability in the study designs (particularly in relation to the reference standard and patient selection due to confounding), and the low level of evidence, suggest that limited conclusions can be drawn from the data.

BIG-bench Machine Learning Specificity